NASDAQ:INMD InMode (INMD) Stock Price, News & Analysis → Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad) Free INMD Stock Alerts $17.41 +0.07 (+0.40%) (As of 04/19/2024 ET) Add Compare Share Share Today's Range$16.96▼$17.5750-Day Range$17.34▼$26.4952-Week Range$16.96▼$48.25Volume1.93 million shsAverage Volume1.60 million shsMarket Capitalization$1.46 billionP/E Ratio7.57Dividend YieldN/APrice Target$32.80 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipShort InterestSocial Media Get InMode alerts: Email Address InMode MarketRank™ Stock AnalysisAnalyst RatingHold2.33 Rating ScoreUpside/Downside88.4% Upside$32.80 Price TargetShort InterestHealthy7.04% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.18Based on 12 Articles This WeekInsider TradingN/AProj. Earnings Growth7.84%From $2.04 to $2.20 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.13 out of 5 starsMedical Sector334th out of 911 stocksElectromedical Equipment Industry4th out of 18 stocks 3.2 Analyst's Opinion Consensus RatingInMode has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 2 buy ratings, 4 hold ratings, and no sell ratings.Amount of Analyst CoverageInMode has only been the subject of 3 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted7.04% of the outstanding shares of InMode have been sold short.Short Interest Ratio / Days to CoverInMode has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in InMode has recently decreased by 2.96%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldInMode does not currently pay a dividend.Dividend GrowthInMode does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for INMD. Previous Next 2.3 News and Social Media Coverage News SentimentInMode has a news sentiment score of 0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.52 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 12 news articles for InMode this week, compared to 7 articles on an average week.Search Interest32 people have searched for INMD on MarketBeat in the last 30 days. This is an increase of 45% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added InMode to their MarketBeat watchlist in the last 30 days. This is a decrease of -70% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, InMode insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.92% of the stock of InMode is held by insiders.Percentage Held by Institutions68.04% of the stock of InMode is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for InMode are expected to grow by 7.84% in the coming year, from $2.04 to $2.20 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InMode is 7.57, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 139.12.Price to Earnings Ratio vs. SectorThe P/E ratio of InMode is 7.57, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 233.90.Price to Book Value per Share RatioInMode has a P/B Ratio of 2.61. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Paradigm PressBitcoin Rockets To Record High But Buy THIS InsteadRecently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. About InMode Stock (NASDAQ:INMD)InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.Read More INMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INMD Stock News HeadlinesApril 16, 2024 | americanbankingnews.comInMode (NASDAQ:INMD) Sets New 1-Year Low on Analyst DowngradeApril 15, 2024 | markets.businessinsider.comFINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of InModeApril 20, 2024 | Paradigm Press (Ad)Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.April 15, 2024 | prnewswire.comINMD DEADLINE TODAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages InMode Ltd. Investors to Secure Counsel Before Important April 15 Deadline in Securities Class Action - INMDApril 15, 2024 | stockhouse.comFINAL INMD DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds InMode Ltd. Investors to Join the Class Action Lawsuit!April 15, 2024 | prnewswire.comShareholders of InMode Ltd. Should Contact Levi & Korsinsky Before April 15, 2024 to Discuss Your Rights - INMDApril 15, 2024 | prnewswire.comFINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in InMode Ltd. with Losses of $500,000 to Contact the FirmApril 14, 2024 | americanbankingnews.comBarclays Lowers InMode (NASDAQ:INMD) Price Target to $33.00April 20, 2024 | Paradigm Press (Ad)Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.April 13, 2024 | nasdaq.comRSI Alert: InMode (INMD) Now OversoldApril 13, 2024 | prnewswire.comINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of InModeApril 12, 2024 | msn.com3 Best Stocks to Buy Now, 4/12/2024, According to Top AnalystsApril 12, 2024 | prnewswire.comINMD Investors Have Opportunity to Lead InMode Ltd. Securities Fraud LawsuitApril 12, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against InMode Ltd.- INMDApril 12, 2024 | prnewswire.comShareholders that lost money on InMode Ltd.(INMD) should contact The Gross Law Firm about pending Class Action - INMDApril 11, 2024 | stockhouse.comThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against InMode Ltd. (INMD)April 11, 2024 | msn.com3 Reasons I'd Consider Selling InMode’s Unusually Active Put OptionApril 11, 2024 | businesswire.comThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against InMode Ltd.April 11, 2024 | stockhouse.com4-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in InMode Ltd. with Losses of $500,000 to Contact the FirmApril 11, 2024 | americanbankingnews.comInMode (NASDAQ:INMD) Sets New 52-Week Low at $18.20April 10, 2024 | prnewswire.comInMode Ltd. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - INMDApril 10, 2024 | americanbankingnews.comInMode (NASDAQ:INMD) Receives Hold Rating from Needham & Company LLCApril 10, 2024 | americanbankingnews.comInMode Target of Unusually High Options Trading (NASDAQ:INMD)April 9, 2024 | stockhouse.comINVESTOR DEADLINE MONDAY: InMode Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - INMDApril 9, 2024 | msn.comInMode slips after guidance cutApril 9, 2024 | prnewswire.comInMode to Report First Quarter 2024 Financial Results and Hold Conference Call May 2, 2024April 9, 2024 | prnewswire.comInvestors in InMode Ltd. Should Contact The Gross Law Firm Before April 15, 2024 to Discuss Your Rights - INMDSee More Headlines Receive INMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InMode and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/13/2024Today4/19/2024Next Earnings (Confirmed)5/02/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:INMD CUSIPN/A CIK885988 Webwww.inmodemd.com Phone972-4909-7470FaxN/AEmployees581Year Founded2008Price Target and Rating Average Stock Price Target$32.80 High Stock Price Target$61.00 Low Stock Price Target$22.00 Potential Upside/Downside+88.4%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)$2.30 Trailing P/E Ratio7.57 Forward P/E Ratio8.53 P/E GrowthN/ANet Income$197.92 million Net Margins40.22% Pretax Margin44.30% Return on Equity29.80% Return on Assets27.02% Debt Debt-to-Equity RatioN/A Current Ratio12.51 Quick Ratio11.87 Sales & Book Value Annual Sales$492.05 million Price / Sales2.97 Cash Flow$2.21 per share Price / Cash Flow7.89 Book Value$6.68 per share Price / Book2.61Miscellaneous Outstanding Shares83,982,000Free Float78,170,000Market Cap$1.46 billion OptionableOptionable Beta2.16 Social Links 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Yair Malca (Age 46)Chief Financial Officer Comp: $581kMs. Nava Tal-LaunerChief Information OfficerMr. Shakil Lakhani (Age 41)President of North America Comp: $3.49MMr. Moshe Mizrahy (Age 71)Chairman & CEO Comp: $216kMr. Alon YaariVice President of OperationsDr. Michael Kreindel (Age 56)CTO & Director Comp: $221kDr. Spero Theodorou M.D. (Age 52)Chief Medical Officer Comp: $1.84MMore ExecutivesKey CompetitorsSoleno TherapeuticsNASDAQ:SLNONatus MedicalNASDAQ:NTUSBioLife SolutionsNASDAQ:BLFSCONMEDNYSE:CNMDZynexNASDAQ:ZYXIView All CompetitorsInstitutional OwnershipTaylor Frigon Capital Management LLCSold 1,027 shares on 4/19/2024Ownership: 0.131%Wasatch Advisors LPBought 103,946 shares on 4/18/2024Ownership: 0.389%Allspring Global Investments Holdings LLCBought 691 shares on 4/18/2024Ownership: 0.009%Tributary Capital Management LLCBought 3,000 shares on 4/18/2024Ownership: 0.004%IMC Chicago LLCBought 131,700 shares on 4/13/2024Ownership: 0.000%View All Institutional Transactions INMD Stock Analysis - Frequently Asked Questions Should I buy or sell InMode stock right now? 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for InMode in the last twelve months. There are currently 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" INMD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INMD, but not buy additional shares or sell existing shares. View INMD analyst ratings or view top-rated stocks. What is InMode's stock price target for 2024? 6 brokerages have issued twelve-month price targets for InMode's stock. Their INMD share price targets range from $22.00 to $61.00. On average, they predict the company's share price to reach $32.80 in the next twelve months. This suggests a possible upside of 88.4% from the stock's current price. View analysts price targets for INMD or view top-rated stocks among Wall Street analysts. How have INMD shares performed in 2024? InMode's stock was trading at $22.24 at the beginning of 2024. Since then, INMD shares have decreased by 21.7% and is now trading at $17.41. View the best growth stocks for 2024 here. When is InMode's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our INMD earnings forecast. How can I listen to InMode's earnings call? InMode will be holding an earnings conference call on Thursday, May 2nd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-0088 with passcode "9531570". How were InMode's earnings last quarter? InMode Ltd. (NASDAQ:INMD) released its quarterly earnings data on Tuesday, February, 13th. The healthcare company reported $0.71 earnings per share for the quarter, beating analysts' consensus estimates of $0.66 by $0.05. The healthcare company had revenue of $126.80 million for the quarter, compared to analyst estimates of $124.77 million. InMode had a trailing twelve-month return on equity of 29.80% and a net margin of 40.22%. The business's revenue was down 5.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.69 EPS. What ETFs hold InMode's stock? ETFs with the largest weight of InMode (NASDAQ:INMD) stock in their portfolio include ARK Israel Innovative Technology ETF (IZRL), Amplify BlueStar Israel Technology ETF (ITEQ) and VanEck Israel ETF (ISRA).iShares MSCI Israel ETF (EIS). When did InMode's stock split? InMode shares split before market open on Thursday, September 30th 2021. The 2-1 split was announced on Friday, September 17th 2021. The newly created shares were distributed to shareholders after the closing bell on Monday, September 27th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. What guidance has InMode issued on next quarter's earnings? InMode updated its FY 2024 earnings guidance on Tuesday, April, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $485.0 million-$495.0 million, compared to the consensus revenue estimate of $498.8 million. What is Moshe Mizrahy's approval rating as InMode's CEO? 1 employees have rated InMode Chief Executive Officer Moshe Mizrahy on Glassdoor.com. Moshe Mizrahy has an approval rating of 100% among the company's employees. This puts Moshe Mizrahy in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of InMode own? Based on aggregate information from My MarketBeat watchlists, some companies that other InMode investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Micron Technology (MU), AbbVie (ABBV), Advanced Micro Devices (AMD), Block (SQ), Tesla (TSLA), DocuSign (DOCU) and PayPal (PYPL). When did InMode IPO? InMode (INMD) raised $75 million in an initial public offering (IPO) on Thursday, August 8th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Barclays, UBS Investment Bank and Canaccord Genuity acted as the underwriters for the IPO and Baird was co-manager. Who are InMode's major shareholders? InMode's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Wasatch Advisors LP (0.39%), IMC Chicago LLC (0.00%), Taylor Frigon Capital Management LLC (0.13%), Allspring Global Investments Holdings LLC (0.01%) and Tributary Capital Management LLC (0.00%). How do I buy shares of InMode? Shares of INMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Does InMode have any subsidiaries? The following companies are subsidiares of InMode: Guangzhou InMode Medical Technology Ltd., InMode Asia Limited., InMode India Private Limited, InMode Japan KK, InMode M.D. Ltd., Invasix Corp., Invasix Iberia S.L., Invasix Inc., and Invasix UK Ltd..Read More This page (NASDAQ:INMD) was last updated on 4/20/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaYour Money is Not SafeAmerican AlternativeThe #1 Crypto for 2024InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent alert: open this for a huge profit potentialTimothy SykesTiny Biotech Stock Wins $75 Billion PatentBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMode Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.